コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 to identify periods of sudden escalation of scarlet fever.
2 o had been treated for ailments unrelated to scarlet fever.
3 muscle fibers, the inner ear, leukaemia, and scarlet fever.
4 were not higher than those in patients with scarlet fever.
5 ultation rates was estimated for empyema and scarlet fever.
8 pyogenes emm genotypes, and notifications of scarlet fever and invasive disease in 2014-16 using regi
11 tococcal SAgs are known virulence factors in scarlet fever and toxic shock syndrome, mechanisms by ho
12 om acute rheumatic fever (ARF) and untreated scarlet fever and/or pharyngitis patients were reacted w
13 ignated M1(UK))-with overlap of pharyngitis, scarlet fever, and invasive M1(UK) strains-which could b
14 resistance genes triggered the expansion of scarlet fever-associated emm12 lineages in Hong Kong.
15 early periodicity in population incidence of scarlet fever but of consistently lower magnitude than t
16 sidered a non-entity, perhaps a mild form of scarlet fever, but certainly not a distinct disease.
17 sults offer insight into the pathogenesis of scarlet fever-causing GAS mediated by prophage PhiHKU.vi
19 We cultured throat swabs from children with scarlet fever, classroom contacts, and household contact
20 ments associated with the expansion of emm12 scarlet fever clones in the M1T1 genomic background.
22 ogenes (group A Streptococcus, GAS) to cause scarlet fever has been linked epidemiologically to the p
28 .011, 95% CI [1.006, 1.015]; p < 0.001), and scarlet fever (IRR: 2.942, 95% CI [2.918, 2.966]; p < 0.
32 ed surveillance study, we analysed statutory scarlet fever notifications held by Public Health Englan
34 al pyrogenic exotoxin A (SpeA; also known as scarlet fever or erythrogenic toxin A) in sequenced, non
36 ment of cases and enhanced hygiene measures, scarlet fever outbreaks increased in England between 201
37 ive tuberculosis test results, strep throat, scarlet fever, pneumonia, bacterial meningitis, yeast in
39 s were seen for hospital-acquired pneumonia, scarlet fever, pyelonephritis, and complicated urinary t
42 urrence of multidrug-resistant ssa-harboring scarlet fever strains should prompt heightened surveilla
43 ncluding pharyngitis, tonsillitis, impetigo, scarlet fever, streptococcal toxic shock syndrome, necro
44 ncluding streptococcal pyrogenic exotoxin A (scarlet fever toxin) and two uncharacterized pyrogenic e
45 to disentangle the enigma: The 116 cases of scarlet fever were compared with 117 "controls" selected
47 and is experiencing an unprecedented rise in scarlet fever with the highest incidence for nearly 50 y
48 articipate if they had reported two cases of scarlet fever within 10 days of each other among childre